Breakthrough Study in HCV Treatment Findings from the University at Buffalo A groundbreaking study from the University at Buffalo, featured in JAMA, has made a compelling case for telemedicine as a game-changer in treating Hepatitis C (HCV) within opioid treatment programs (OTPs). The research
Telemedicine: A Game-Changer in HCV Healthcare Reaching the Underserved Populations In a groundbreaking study led by Andrew Talal, MD, telemedicine has demonstrated a remarkable impact on the treatment accessibility for individuals with hepatitis C virus (HCV) in the context of opioid use disorder.
The World Health Organization is embracing generative AI with its Smart AI Resource Assistant for Health (S.A.R.A.H.), a leap in health education accessibility. This digital assistant breaks down language and digital literacy barriers by offering immediate, tailored health conversations in eight
